Company / Current Assets
KYNTRA BIO, INC. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$99.1M
FY2025
5-year range
$99.1M / $755.1M
FY2021-FY2025
Trend
-49.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has declined for 4 consecutive years, from $755M in FY2021 to $99M in FY2025.
Based on SEC 10-K filings.
$99M in FY2025 with a 5-year CAGR of -33.4%.
Declined from $332M to $99M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -41.4%
- 5-Year CAGR
- -33.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- KYNTRA BIO, INC.'s current assets has declined for 4 consecutive years.
- 5-year CAGR of -33.4%, indicating a declining trend.
- In FY2025, current assets decreased 49.6% year-over-year.
- Peak current assets was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -3.33 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $99.1M | -49.6% |
| FY2024 | $196.5M | -40.7% |
| FY2023 | $331.6M | -32.7% |
| FY2022 | $492.8M | -34.7% |
| FY2021 | $755.1M | +0.0% |
| FY2020 | $755.1M | +7.5% |
| FY2019 | $702.5M | +1.8% |
| FY2018 | $690.0M | -7.9% |
| FY2017 | $749.0M | +181.0% |
| FY2016 | $266.5M | +32.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026